Alliance Forms to Advance Vaccines for Neglected Diseases

August 16, 2017

Pharmaceutical Executive

MilliporeSigma announced an alliance it has formed with Baylor College of Medicine, located in Houston, Texas, and its vaccine product development partnership (PDP)-Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD). The purpose of the alliance is to progress vaccine research and development (R&D) for neglected and emerging infections.  

 

MilliporeSigma announced an alliance it has formed with Baylor College of Medicine, located in Houston, Texas, and its vaccine product development partnership (PDP)-Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD). The purpose of the alliance is to progress vaccine research and development (R&D) for neglected and emerging infections.
 

MilliporeSigma’s process development and formulation team are working with Texas Children’s CVD scientists at Baylor to improve the manufacturing process of vaccines for increased stability and yield. To start, they will be targeting schistosomiasis, a deadly parasitic disease that affects millions of people a year in tropical and subtropical regions.